MedTrace Logo

HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia

NCT06127290 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-02-27

No results posted yet for this study

Summary

Cohort based prospective monitoring of the spread of HIV drug resistance during a phase when new anti-HIV drugs are introduced.

Conditions

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER

  • University of Siena

    collaborator OTHER

  • University Hospital of Cologne

    collaborator OTHER

  • Pomeranian Medical University Szczecin

    collaborator OTHER

  • Euresist Network GEIE

    lead OTHER

Principal Investigators

  • FRANCESCA INCARDONA · Euresist Network GEIE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2025-03-31
Completion
2025-05-31

Countries

  • Germany
  • Italy
  • Poland
  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06127290 on ClinicalTrials.gov